Events › Healthcare & MedTech
Healthcare & MedTech
The 5th Annual AI Drug Discovery & Development Summit 2026 (AIDDD) in Boston is a B2B event focusing on deploying AI across the pharmaceutical value chain, from target identification to clinical trials, featuring over 1,000 industry practitioners.
Attendees: Leaders from pharma, biotech, AI technology companies, academia, and investors
Exhibitor mix: Partners and sponsors categorized by tier (Platinum, Gold, Silver) including AI platform providers, biotech services, and cloud computing.
Filter this event to your ICP.
Dozens of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
Venue
Boston Marriott Copley PlaceHotel venue · 6,503 m² · 1 halls · ~2,600 people
A 4-star hotel located in Boston's Back Bay, featuring over 70,000 square feet of total meeting and convention space, including a large grand ballroom and 47 meeting rooms, connected to the Copley Place Mall.
📍 110 Huntington Ave, Boston, MA 02116, USA
Operated by Marriott International
Organizer
Kisaco ResearchPrivate · London, United Kingdom · Founded 2013
Organizes high-level B2B events for industries including animal health, AI, and agriculture.
Exhibitor list
30 companies are exhibiting at AI Drug Discovery & Development Summit. A sample of 12 is shown below — unlock the full list to see all 30.
18 more exhibitors at AI Drug Discovery & Development Summit.
Unlock the complete exhibitor list — every company, with optional ICP filtering and verified buying-committee contacts per matched account.
Why people attend
To discover AI-driven technologies to speed up drug discovery, reduce costs, and improve R&D efficiency.
Exhibitor categories
Speakers
85 speakers at AI Drug Discovery & Development Summit
Senior Director - Data & Computational Sciences · Vertex
"Federated Learning to Build Models in Proprietary Data without Data Sharing"
Chief Medical Affairs Officer, Medical Engagement and Impact · Pfizer
"C-suite Panel: The current state of play for AI deployment in pharma"
Also speaking at HLTH USA
Chief Scientific Officer, Head of Research · Takeda
"C-suite Panel: The current state of play for AI deployment in pharma"
Also speaking at Fierce Biotech Week, BIO International Convention
Professor Emeritus of Anthropology · University of British Columbia
"C-suite Panel: The current state of play for AI deployment in pharma"
Wade Davis served as Explorer-in-Residence at the National Geographic Society (2000-2013) and Professor of Anthropology at the University of British Columbia (2014-2024). His 24 books, published in 23 languages, include the international bestsellers The Serpent and the Rainbow (1985), One River (1996), The Wayfinders (2007), and Into the Silence (2011), winner of the 2012 Samuel Johnson Prize, the top nonfiction award in the English language; recent books include Magdalena: River of Dreams (2020) and Beneath the Surface of Things (2024). One of 20 Honorary Members of the Explorers Club, Davis is the recipient of 12 honorary degrees, as well as the 2009 Gold Medal from the Royal Canadian Geographical Society, the 2011 Explorers Medal, the 2012 David Fairchild Medal for botanical exploration, the 2015 Centennial Medal of Harvard University, the 2017 Roy Chapman Andrews Society’s Distinguished Explorer Award, the 2017 Sir Christopher Ondaatje Medal for Exploration, and the 2018 Mungo Park Medal from the Royal Scottish Geographical Society. A Member of the Order of Canada, he became in 2018 an Honorary Citizen of Colombia.
Also speaking at SXSW Conference & Festivals, IMPACT Sustainability Travel & Tourism Summit
Co-Founder & CEO · Boltz
"Foundation Models: Opportunities, Challenges, and What’s Next"
Co-Founder · Chai Discovery
"Foundation Models: Opportunities, Challenges, and What’s Next"
Head of Search and Evaluation- Respiratory and Immunology · AstraZeneca
"Innovation Showcase & Reverse Pitches"
Also speaking at Fierce Biotech Week, 11th CAR-TCR Summit
Global Innovation Lead · Sanofi
"Innovation Showcase & Reverse Pitches"
Director Innovation and AI strategy · Alexion
"Innovation Showcase & Reverse Pitches"
Senior Director External Innovation · Johnson & Johnson
"Innovation Showcase & Reverse Pitches"
Board Observer · Aerska
"Innovation Showcase & Reverse Pitches"
Also speaking at Fierce Biotech Week
Senior Vice President, Head of Astellas Innovation Lab · Astellas Pharma
"Executive Panel - Operationalizing AI in Discovery Biology: From Target Hypothesis to Translational Decision-Making"
VP and Global Head, AI for Drug Discovery · Roche
"Executive Panel - Operationalizing AI in Discovery Biology: From Target Hypothesis to Translational Decision-Making"
Director of AI · Sigmatic Sciences
"Scaling Scientific Capacity: Giving Every Researcher a Team of AI scientists"
Head of GTM Strategy · Sigmatic Sciences
"Scaling Scientific Capacity: Giving Every Researcher a Team of AI scientists"
VP, Global Head of Target, Disease & Systems Biology · Sanofi
"AI for Mechanism-Driven Precision Medicine: Connecting Target Biology to Patient Context"
Also speaking at 16th World Clinical Biomarkers & Companion Diagnostics Summit
+ 69 more speakers at this event.
More Healthcare & MedTech events
Frequently asked questions